Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study.

Olén O, Erichsen R, Sachs MC, Pedersen L, Halfvarson J, Askling J, Ekbom A, Sørensen HT, Ludvigsson JF.

Lancet. 2020 Jan 11;395(10218):123-131. doi: 10.1016/S0140-6736(19)32545-0.

PMID:
31929014
2.

Juvenile idiopathic arthritis and risk of cancer before and after the introduction of biological therapies.

Horne A, Delcoigne B, Palmblad K, Askling J.

RMD Open. 2019 Nov 13;5(2):e001055. doi: 10.1136/rmdopen-2019-001055. eCollection 2019.

3.

Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis.

Lindström U, Glintborg B, Di Giuseppe D, Nordström D, Aarrestad Provan S, Gudbjornsson B, Askling J, Lund Hetland M, Aaltonen K, Krogh NS, Geirsson AJ, Jacobsson LTH.

RMD Open. 2019 Oct 23;5(2):e001079. doi: 10.1136/rmdopen-2019-001079. eCollection 2019.

4.

Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration.

Ørnbjerg LM, Brahe CH, Askling J, Ciurea A, Mann H, Onen F, Kristianslund EK, Nordström D, Santos MJ, Codreanu C, Gómez-Reino J, Rotar Z, Gudbjornsson B, Di Giuseppe D, Nissen MJ, Pavelka K, Birlik M, Kvien T, Eklund KK, Barcelos A, Ionescu R, Sanchez-Piedra C, Tomsic M, Geirsson ÁJ, Loft AG, van der Horst-Bruinsma I, Jones G, Iannone F, Hyldstrup L, Krogh NS, Hetland ML, Østergaard M.

Ann Rheum Dis. 2019 Nov;78(11):1536-1544. doi: 10.1136/annrheumdis-2019-215427. Epub 2019 Aug 20.

PMID:
31431486
5.

Occupational exposure to asbestos and silica and risk of developing rheumatoid arthritis: findings from a Swedish population-based case-control study.

Ilar A, Klareskog L, Saevarsdottir S, Wiebert P, Askling J, Gustavsson P, Alfredsson L.

RMD Open. 2019 Jul 11;5(2):e000978. doi: 10.1136/rmdopen-2019-000978. eCollection 2019.

6.

Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practice.

Lindström U, Olofsson T, Wedrén S, Qirjazo I, Askling J.

Arthritis Res Ther. 2019 May 28;21(1):128. doi: 10.1186/s13075-019-1908-9.

7.

Correspondence for "Clinical epidemiology of familial sarcoidosis: A systematic literature review".

Rossides M, Grunewald J, Eklund A, Kullberg S, Askling J, Arkema EV.

Respir Med. 2019 Nov - Dec;160:105696. doi: 10.1016/j.rmed.2019.05.003. Epub 2019 May 13. No abstract available.

PMID:
31104964
8.

Mortality in adult-onset and elderly-onset IBD: a nationwide register-based cohort study 1964-2014.

Olén O, Askling J, Sachs MC, Neovius M, Smedby KE, Ekbom A, Ludvigsson JF.

Gut. 2019 May 15. pii: gutjnl-2018-317572. doi: 10.1136/gutjnl-2018-317572. [Epub ahead of print]

PMID:
31092591
9.

Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply.

Frisell T, Askling J.

Rheumatology (Oxford). 2019 Aug 1;58(8):1510-1511. doi: 10.1093/rheumatology/kez120. No abstract available.

PMID:
31056707
10.

Response to: 'Inflammatory and non-inflammatory triggers of acute coronary syndromes' by Eyuboglu.

Westerlind H, Holmqvist M, Ljung L, Frisell T, Askling J.

Ann Rheum Dis. 2019 Mar 28. pii: annrheumdis-2019-215293. doi: 10.1136/annrheumdis-2019-215293. [Epub ahead of print] No abstract available.

PMID:
30923234
11.

Effects of Childhood-onset Inflammatory Bowel Disease on School Performance: A Nationwide Population-based Cohort Study Using Swedish Health and Educational Registers.

Malmborg P, Mouratidou N, Sachs MC, Hammar U, Khalili H, Neovius M, Hjern A, Smedby KE, Ekbom A, Askling J, Ludvigsson JF, Olén O.

Inflamm Bowel Dis. 2019 Mar 27. pii: izz040. doi: 10.1093/ibd/izz040. [Epub ahead of print]

PMID:
30916332
12.

2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis.

Ehlers L, Askling J, Bijlsma HW, Cid MC, Cutolo M, Dasgupta B, Dejaco C, Dixon WG, Feltelius N, Finckh A, Gilbert K, Mackie SL, Mahr A, Matteson EL, Neill L, Salvarani C, Schmidt WA, Strangfeld A, van Vollenhoven RF, Buttgereit F.

Ann Rheum Dis. 2019 Sep;78(9):1160-1166. doi: 10.1136/annrheumdis-2018-214755. Epub 2019 Mar 21.

PMID:
30898837
13.

Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply.

Frisell T, Askling J.

Rheumatology (Oxford). 2019 Aug 1;58(8):1507-1509. doi: 10.1093/rheumatology/kez067. No abstract available.

PMID:
30838417
14.

Siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndrome.

Westerlind H, Holmqvist M, Ljung L, Frisell T, Askling J.

Ann Rheum Dis. 2019 May;78(5):683-687. doi: 10.1136/annrheumdis-2018-214828. Epub 2019 Feb 20.

PMID:
30787006
15.

Fracture Risk in Patients With Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study From 1964 to 2014.

Ludvigsson JF, Mahl M, Sachs MC, Björk J, Michaelsson K, Ekbom A, Askling J, Backman AS, Olén O.

Am J Gastroenterol. 2019 Feb;114(2):291-304. doi: 10.14309/ajg.0000000000000062.

PMID:
30730858
16.

Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients.

Everhov ÅH, Sachs MC, Malmborg P, Nordenvall C, Myrelid P, Khalili H, Elmberg M, Ekbom A, Askling J, Jakobsson G, Halfvarson J, Ludvigsson JF, Olén O.

Scand J Gastroenterol. 2019 Jan;54(1):55-63. doi: 10.1080/00365521.2018.1564361. Epub 2019 Jan 31.

17.

Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register.

Frisell T, Dehlin M, Di Giuseppe D, Feltelius N, Turesson C, Askling J; ARTIS Study Group .

Rheumatology (Oxford). 2019 Jan 21. doi: 10.1093/rheumatology/key433. [Epub ahead of print]

PMID:
30668875
18.

Risk of Thyroxine-Treated Autoimmune Thyroid Disease Associated With Disease Onset in Patients With Rheumatoid Arthritis.

Waldenlind K, Saevarsdottir S, Bengtsson C, Askling J.

JAMA Netw Open. 2018 Oct 5;1(6):e183567. doi: 10.1001/jamanetworkopen.2018.3567.

19.

Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation.

Ljung L, Ueda P, Liao KP, Greenberg JD, Etzel CJ, Solomon DH, Askling J.

RMD Open. 2018 Dec 16;4(2):e000771. doi: 10.1136/rmdopen-2018-000771. eCollection 2018.

20.

Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden.

Grøn KL, Arkema EV, Glintborg B, Mehnert F, Østergaard M, Dreyer L, Nørgaard M, Krogh NS, Askling J, Hetland ML; ARTIS Study Group.

Ann Rheum Dis. 2019 Mar;78(3):320-327. doi: 10.1136/annrheumdis-2018-214326. Epub 2019 Jan 5.

PMID:
30612115
21.

Work Loss Before and After Diagnosis of Crohn's Disease.

Everhov ÅH, Khalili H, Askling J, Myrelid P, Ludvigsson JF, Halfvarson J, Nordenvall C, Neovius M, Söderling J, Olén O.

Inflamm Bowel Dis. 2019 Jun 18;25(7):1237-1247. doi: 10.1093/ibd/izy382.

PMID:
30551185
22.

Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjögren's syndrome.

Vasaitis L, Nordmark G, Theander E, Backlin C, Smedby KE, Askling J, Rönnblom L, Sundström C, Baecklund E.

Scand J Rheumatol. 2019 May;48(3):207-212. doi: 10.1080/03009742.2018.1523456. Epub 2018 Nov 13.

PMID:
30422723
23.

Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study.

Lindström U, Olofsson T, Wedrén S, Qirjazo I, Askling J.

RMD Open. 2018 Oct 15;4(2):e000762. doi: 10.1136/rmdopen-2018-000762. eCollection 2018.

24.

Gastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case-Control Study.

Axelrad JE, Olén O, Askling J, Lebwohl B, Khalili H, Sachs MC, Ludvigsson JF.

Clin Gastroenterol Hepatol. 2019 Jun;17(7):1311-1322.e7. doi: 10.1016/j.cgh.2018.09.034. Epub 2018 Oct 30.

PMID:
30389589
25.

Increased Mortality of Patients With Childhood-Onset Inflammatory Bowel Diseases, Compared With the General Population.

Olén O, Askling J, Sachs MC, Frumento P, Neovius M, Smedby KE, Ekbom A, Malmborg P, Ludvigsson JF.

Gastroenterology. 2019 Feb;156(3):614-622. doi: 10.1053/j.gastro.2018.10.028. Epub 2018 Oct 17.

PMID:
30342031
26.

Pancreatic Cancer Following Acute Pancreatitis: A Population-based Matched Cohort Study.

Sadr-Azodi O, Oskarsson V, Discacciati A, Videhult P, Askling J, Ekbom A.

Am J Gastroenterol. 2018 Nov;113(11):1711-1719. doi: 10.1038/s41395-018-0255-9. Epub 2018 Oct 12.

PMID:
30315287
27.

Cardiovascular risk factors in non-alcoholic fatty liver disease.

Hagström H, Nasr P, Ekstedt M, Hammar U, Stål P, Askling J, Hultcrantz R, Kechagias S.

Liver Int. 2019 Jan;39(1):197-204. doi: 10.1111/liv.13973. Epub 2018 Oct 17.

PMID:
30253056
28.

Sick Leave and Disability Pension in Prevalent Patients With Crohn's Disease.

Everhov ÅH, Khalili H, Askling J, Myrelid P, Ludvigsson JF, Halfvarson J, Nordenvall C, Söderling J, Olén O, Neovius M.

J Crohns Colitis. 2018 Nov 28;12(12):1418-1428. doi: 10.1093/ecco-jcc/jjy123.

PMID:
30165593
29.

Tumor Necrosis Factor Inhibitors and Cancer Recurrence in Swedish Patients With Rheumatoid Arthritis: A Nationwide Population-Based Cohort Study.

Raaschou P, Söderling J, Turesson C, Askling J; ARTIS Study Group.

Ann Intern Med. 2018 Sep 4;169(5):291-299. doi: 10.7326/M17-2812. Epub 2018 Aug 14.

PMID:
30105374
30.

Mediterranean diet and risk of rheumatoid arthritis: a population-based case-control study.

Johansson K, Askling J, Alfredsson L, Di Giuseppe D; EIRA study group.

Arthritis Res Ther. 2018 Aug 9;20(1):175. doi: 10.1186/s13075-018-1680-2.

31.

Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries.

Glintborg B, Lindström U, Aaltonen K, Kristianslund EK, Gudbjornsson B, Chatzidionysiou K, Askling J, Nordström D, Hetland ML, Di Giuseppe D, Dreyer L, Kristensen LE, Jørgensen TS, Eklund K, Grondal G, Ernestam S, Joensuu J, Törmänen M, Skydsgaard H, Hagfors J, Kvien TK, Lie E, Fagerli K, Geirsson AJ, Jonsson H, Provan SA, Krogh NS, Jacobsson L.

Scand J Rheumatol. 2018 Nov;47(6):465-474. doi: 10.1080/03009742.2018.1444199. Epub 2018 Aug 2.

PMID:
30070923
32.

Familial aggregation and heritability of sarcoidosis: a Swedish nested case-control study.

Rossides M, Grunewald J, Eklund A, Kullberg S, Di Giuseppe D, Askling J, Arkema EV.

Eur Respir J. 2018 Aug 16;52(2). pii: 1800385. doi: 10.1183/13993003.00385-2018. Print 2018 Aug.

PMID:
29946010
33.

Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example.

Chatzidionysiou K, Hetland ML, Frisell T, Di Giuseppe D, Hellgren K, Glintborg B, Nordström D, Aaltonen K, Törmänen MR, Klami Kristianslund E, Kvien TK, Provan SA, Björn Guðbjörnsson B, Dreyer L, Kristensen LE, Jørgensen TS, Jacobsson L, Askling J.

RMD Open. 2018 Apr 12;4(1):e000655. doi: 10.1136/rmdopen-2018-000655. eCollection 2018. Review. Erratum in: RMD Open. 2018 May 14;4(1):.

34.

Uptake of rheumatology biosimilars in the absence of forced switching.

Di Giuseppe D, Frisell T, Ernestam S, Forsblad-D'Elia H, Lindqvist E, Lindström U, Sjöwall C, Askling J; ARTIS group.

Expert Opin Biol Ther. 2018 May;18(5):499-504. doi: 10.1080/14712598.2018.1458089. Epub 2018 Apr 10.

35.

Transmission of rheumatoid arthritis through blood transfusion: a retrospective cohort study.

Just SA, Rostgaard K, Titlestad K, Edgren G, Erikstrup C, Ullum H, Pedersen OB, Nielsen KR, Askling J, Lindegaard H, Hjalgrim H.

Ann Rheum Dis. 2018 Oct;77(10):1536-1537. doi: 10.1136/annrheumdis-2017-212844. Epub 2018 Mar 1. No abstract available.

PMID:
29496719
36.

Sarcoidosis mortality in Sweden: a population-based cohort study.

Rossides M, Kullberg S, Askling J, Eklund A, Grunewald J, Arkema EV.

Eur Respir J. 2018 Feb 21;51(2). pii: 1701815. doi: 10.1183/13993003.01815-2017. Print 2018 Feb.

37.

Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis.

Baecklund E, Backlin C, Rönnelid J, Toes R, Huizinga T, Åhlin E, Askling J, Hochberg FH, Klareskog L, Kay J, Smedby KE.

Scand J Rheumatol. 2018 Jul;47(4):270-275. doi: 10.1080/03009742.2017.1376108. Epub 2018 Jan 16.

PMID:
29336646
38.

2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis.

Radner H, Chatzidionysiou K, Nikiphorou E, Gossec L, Hyrich KL, Zabalan C, van Eijk-Hustings Y, Williamson PR, Balanescu A, Burmester GR, Carmona L, Dougados M, Finckh A, Haugeberg G, Hetland ML, Oliver S, Porter D, Raza K, Ryan P, Santos MJ, van der Helm-van Mil A, van Riel P, von Krause G, Zavada J, Dixon WG, Askling J.

Ann Rheum Dis. 2018 Apr;77(4):476-479. doi: 10.1136/annrheumdis-2017-212256. Epub 2018 Jan 4.

PMID:
29301783
39.

Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from Sweden.

Bengtsson K, Forsblad-d'Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, Lindström U, Askling J, Jacobsson LTH.

Ann Rheum Dis. 2018 Apr;77(4):541-548. doi: 10.1136/annrheumdis-2017-212189. Epub 2017 Dec 19.

PMID:
29259045
40.

Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.

Frisell T, Baecklund E, Bengtsson K, Di Giuseppe D, Forsblad-d'Elia H, Askling J; ARTIS Study group.

Ann Rheum Dis. 2018 May;77(5):650-657. doi: 10.1136/annrheumdis-2017-212395. Epub 2017 Dec 13.

41.

Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study.

de Vries MK, Arkema EV, Jonsson J, Bruchfeld J, Jacobsson LTH, Askling J; ARTIS Study Group.

Arthritis Care Res (Hoboken). 2018 Oct;70(10):1563-1567. doi: 10.1002/acr.23487. Epub 2018 Sep 4.

42.

Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.

Everhov ÅH, Halfvarson J, Myrelid P, Sachs MC, Nordenvall C, Söderling J, Ekbom A, Neovius M, Ludvigsson JF, Askling J, Olén O.

Gastroenterology. 2018 Feb;154(3):518-528.e15. doi: 10.1053/j.gastro.2017.10.034. Epub 2017 Nov 2.

PMID:
29102619
43.

Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme.

Yamanaka H, Askling J, Berglind N, Franzen S, Frisell T, Garwood C, Greenberg JD, Ho M, Holmqvist M, Novelli Horne L, Inoue E, Michaud K, Pappas DA, Reed G, Symmons D, Tanaka E, Tran TN, Verstappen SMM, Wesby-van Swaay E, Nyberg F.

RMD Open. 2017 Oct 10;3(2):e000498. doi: 10.1136/rmdopen-2017-000498. eCollection 2017.

44.

Surgical Treatment in Childhood-onset Inflammatory Bowel Disease-A Nationwide Register-based Study of 4695 Incident Patients in Sweden 2002-2014.

Nordenvall C, Rosvall O, Bottai M, Everhov ÅH, Malmborg P, Smedby KE, Ekbom A, Askling J, Ludvigsson JF, Myrelid P, Olén O.

J Crohns Colitis. 2018 Jan 24;12(2):157-166. doi: 10.1093/ecco-jcc/jjx132.

PMID:
29029152
45.

Seropositivity combined with smoking is associated with increased prevalence of periodontitis in patients with rheumatoid arthritis.

Eriksson K, Nise L, Alfredsson L, Catrina AI, Askling J, Lundberg K, Klareskog L, Yucel-Lindberg T.

Ann Rheum Dis. 2018 Aug;77(8):1236-1238. doi: 10.1136/annrheumdis-2017-212091. Epub 2017 Oct 6. No abstract available.

46.

Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice: A Nationwide Cohort Study From Sweden.

Wadström H, Frisell T, Askling J; Anti-Rheumatic Therapy in Sweden (ARTIS) Study Group.

JAMA Intern Med. 2017 Nov 1;177(11):1605-1612. doi: 10.1001/jamainternmed.2017.4332.

47.

Mortality following new-onset Rheumatoid Arthritis: has modern Rheumatology had an impact?

Holmqvist M, Ljung L, Askling J.

Ann Rheum Dis. 2018 Jan;77(1):85-91. doi: 10.1136/annrheumdis-2017-212131. Epub 2017 Sep 26.

PMID:
28970218
48.

Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014.

Olén O, Askling J, Sachs MC, Frumento P, Neovius M, Smedby KE, Ekbom A, Malmborg P, Ludvigsson JF.

BMJ. 2017 Sep 20;358:j3951. doi: 10.1136/bmj.j3951.

49.

Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis.

Mantel Ä, Holmqvist M, Jernberg T, Wållberg-Jonsson S, Askling J.

Ann Rheum Dis. 2017 Dec;76(12):2017-2024. doi: 10.1136/annrheumdis-2017-211608. Epub 2017 Aug 20.

PMID:
28823986
50.

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project.

Mercer LK, Regierer AC, Mariette X, Dixon WG, Baecklund E, Hellgren K, Dreyer L, Hetland ML, Cordtz R, Hyrich K, Strangfeld A, Zink A, Canhao H, Hernandez MV, Tubach F, Gottenberg JE, Morel J, Zavada J, Iannone F, Askling J, Listing J.

Ann Rheum Dis. 2017 Dec;76(12):2025-2030. doi: 10.1136/annrheumdis-2017-211623. Epub 2017 Aug 19.

Supplemental Content

Loading ...
Support Center